Myomo (MYO) director buys 50,000 shares at $1.15 — holding 474,420
Myomo, Inc. director Thomas F. Kirk reported an open-market purchase of 50,000 shares of Myomo common stock on 08/25/2025 at an execution price of $1.15 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Myomo, Inc. director Thomas F. Kirk reported an open-market purchase of 50,000 shares of Myomo common stock on 08/25/2025 at an execution price of $1.15 per share. After the transaction the reporting person beneficially owns 474,420 shares, held directly. The Form 4 was signed by an attorney-in-fact on 08/26/2025. The filing states the purchases occurred in multiple lots at $1.15 per share and that the reporting party will provide transaction details to the SEC upon request. No derivative transactions, dispositions, or additional securities classes are reported.
Positive
- Director open-market purchase of 50,000 shares shows insider acquisition and increased direct ownership to 474,420 shares.
- Clear disclosure of transaction date, price ($1.15) and that purchases were executed in multiple lots; attorney-in-fact signature provided.
Negative
- None.
Insights
TL;DR: A director bought 50,000 shares at $1.15, increasing direct holdings to 474,420 shares; the trade is disclosed via Form 4.
The open-market purchase by a director is a straightforward insider acquisition disclosed under Section 16. The size—50,000 shares—is material relative to the director's total direct holding disclosed here, raising his direct stake to 474,420 shares. The reported execution price of $1.15 per share and the statement that purchases occurred in multiple lots are explicitly documented. This Form 4 contains no information about motives, funding source, or planned future transactions, so market-impact conclusions cannot be drawn from the filing alone.
TL;DR: Director timely reported open-market purchases; disclosure appears complete for the non-derivative transaction listed.
The filing satisfies basic Section 16 reporting: it identifies the reporting person as a director, lists the transaction date, transaction code (P for open-market purchase), amount, price, and post-transaction beneficial ownership. The explanation clarifies multiple-lot purchases at $1.15 and offers to provide lot-level details to the SEC on request. There are no indications of Rule 10b5-1 plan usage or coordinated filings. For governance review, the disclosure is routine and compliant based on the provided content.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 50,000 | $1.15 | $57K |
Footnotes (2)
- F1. Represents open market purchases.
- F2. Shares were purchased in multiple lots, each executing at $1.15 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Myomo (MYO) disclose on Form 4?
Was the Form 4 transaction a purchase or sale and what transaction code was used?
Who signed the Form 4 for the reporting person?
AI-generated analysis. How Rhea-AI works. Not financial advice.